Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Are You Thankful for Workers’ Comp? 2021
It’s Thanksgiving week and, as most of our listeners know, it’s time when Inside Workers’ Comp celebrates our annual tradition by presenting our “Why We’re Thankful for Workers’ Comp” episode.
mPower Conference Session: Auto Casualty Trends
In this recorded session, Mitchell | Genex | Coventry experts will share insights into the most important claim, technology, pharmacy and regulatory trends in the auto casualty industry today, with a focus on first party auto.
Release of Generic Medications for Workers' Comp in 2022
Next year twenty-eight drugs relevant to workers’ compensation are expected to become available as generics. These formulations will be made available once the original drug manufacturer’s brand name period of exclusivity has expired.
Nina Smith: Navigating Next – Lessons Learned from within a Workers’ Comp Consolidation
Nina Smith: Adaptability – Listening to Customers During COVID-19
Modifications to Living Spaces Make Injured Workers Feel at Home
When a 33-year-old man was grievously injured at work, the last thing he might have expected he would need as part of his recovery was a real estate agent.